IBDEI29U ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,36264,1,3,0)
;;=3^Thoracic DDD w/o Radiculopathy
;;^UTILITY(U,$J,358.3,36264,1,4,0)
;;=4^M51.24
;;^UTILITY(U,$J,358.3,36264,2)
;;=^5012247
;;^UTILITY(U,$J,358.3,36265,0)
;;=M51.15^^139^1841^1
;;^UTILITY(U,$J,358.3,36265,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,36265,1,3,0)
;;=3^T-L DDD w/ Radiculopathy
;;^UTILITY(U,$J,358.3,36265,1,4,0)
;;=4^M51.15
;;^UTILITY(U,$J,358.3,36265,2)
;;=^5012244
;;^UTILITY(U,$J,358.3,36266,0)
;;=Z02.5^^139^1842^1
;;^UTILITY(U,$J,358.3,36266,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,36266,1,3,0)
;;=3^Exam for Sports Participation (Primary)
;;^UTILITY(U,$J,358.3,36266,1,4,0)
;;=4^Z02.5
;;^UTILITY(U,$J,358.3,36266,2)
;;=^5062638
;;^UTILITY(U,$J,358.3,36267,0)
;;=20600^^140^1843^5^^^^1
;;^UTILITY(U,$J,358.3,36267,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36267,1,2,0)
;;=2^Drain/Inject, Joint/Bursa
;;^UTILITY(U,$J,358.3,36267,1,3,0)
;;=3^20600
;;^UTILITY(U,$J,358.3,36268,0)
;;=20605^^140^1843^1^^^^1
;;^UTILITY(U,$J,358.3,36268,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36268,1,2,0)
;;=2^Asp/Inj Interm Jt(Ac/Wrist/Ankle
;;^UTILITY(U,$J,358.3,36268,1,3,0)
;;=3^20605
;;^UTILITY(U,$J,358.3,36269,0)
;;=20610^^140^1843^2^^^^1
;;^UTILITY(U,$J,358.3,36269,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36269,1,2,0)
;;=2^Asp/Inj Maj Jt (Should/Hip/Knee
;;^UTILITY(U,$J,358.3,36269,1,3,0)
;;=3^20610
;;^UTILITY(U,$J,358.3,36270,0)
;;=20550^^140^1843^6^^^^1
;;^UTILITY(U,$J,358.3,36270,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36270,1,2,0)
;;=2^Inject Tendon/Ligament/Cyst
;;^UTILITY(U,$J,358.3,36270,1,3,0)
;;=3^20550
;;^UTILITY(U,$J,358.3,36271,0)
;;=J1100^^140^1843^4^^^^1
;;^UTILITY(U,$J,358.3,36271,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36271,1,2,0)
;;=2^Dexamethasone Sodium Phos 1 mg
;;^UTILITY(U,$J,358.3,36271,1,3,0)
;;=3^J1100
;;^UTILITY(U,$J,358.3,36272,0)
;;=J0800^^140^1843^3^^^^1
;;^UTILITY(U,$J,358.3,36272,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36272,1,2,0)
;;=2^Corticotropin Inj up to 40 units
;;^UTILITY(U,$J,358.3,36272,1,3,0)
;;=3^J0800
;;^UTILITY(U,$J,358.3,36273,0)
;;=J1040^^140^1843^7^^^^1
;;^UTILITY(U,$J,358.3,36273,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36273,1,2,0)
;;=2^Methylprednisolone 80 Mg Inj
;;^UTILITY(U,$J,358.3,36273,1,3,0)
;;=3^J1040
;;^UTILITY(U,$J,358.3,36274,0)
;;=20552^^140^1843^8^^^^1
;;^UTILITY(U,$J,358.3,36274,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36274,1,2,0)
;;=2^Trigger Point(s) Inj,1-2 Muscles
;;^UTILITY(U,$J,358.3,36274,1,3,0)
;;=3^20552
;;^UTILITY(U,$J,358.3,36275,0)
;;=20553^^140^1843^9^^^^1
;;^UTILITY(U,$J,358.3,36275,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36275,1,2,0)
;;=2^Trigger Point(s) Inj,=/> 3 Muscles
;;^UTILITY(U,$J,358.3,36275,1,3,0)
;;=3^20553
;;^UTILITY(U,$J,358.3,36276,0)
;;=J0588^^140^1843^10^^^^1
;;^UTILITY(U,$J,358.3,36276,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36276,1,2,0)
;;=2^Xeomin (Incobotulinumtoxin A) 1 Unit
;;^UTILITY(U,$J,358.3,36276,1,3,0)
;;=3^J0588
;;^UTILITY(U,$J,358.3,36277,0)
;;=97597^^140^1844^2^^^^1
;;^UTILITY(U,$J,358.3,36277,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,36277,1,2,0)
;;=2^Active Wound Care/20 Cm Or <
;;^UTILITY(U,$J,358.3,36277,1,3,0)
;;=3^97597
;;^UTILITY(U,$J,358.3,36278,0)
;;=97598^^140^1844^1^^^^1
;;^UTILITY(U,$J,358.3,36278,1,0)
;;=^358.31IA^3^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI29U 3760 printed Apr 09, 2024@21:13:14 Page 2
IBDEI29U ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,36264,1,3,0)
+2 ;;=3^Thoracic DDD w/o Radiculopathy
+3 ;;^UTILITY(U,$J,358.3,36264,1,4,0)
+4 ;;=4^M51.24
+5 ;;^UTILITY(U,$J,358.3,36264,2)
+6 ;;=^5012247
+7 ;;^UTILITY(U,$J,358.3,36265,0)
+8 ;;=M51.15^^139^1841^1
+9 ;;^UTILITY(U,$J,358.3,36265,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,36265,1,3,0)
+12 ;;=3^T-L DDD w/ Radiculopathy
+13 ;;^UTILITY(U,$J,358.3,36265,1,4,0)
+14 ;;=4^M51.15
+15 ;;^UTILITY(U,$J,358.3,36265,2)
+16 ;;=^5012244
+17 ;;^UTILITY(U,$J,358.3,36266,0)
+18 ;;=Z02.5^^139^1842^1
+19 ;;^UTILITY(U,$J,358.3,36266,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,36266,1,3,0)
+22 ;;=3^Exam for Sports Participation (Primary)
+23 ;;^UTILITY(U,$J,358.3,36266,1,4,0)
+24 ;;=4^Z02.5
+25 ;;^UTILITY(U,$J,358.3,36266,2)
+26 ;;=^5062638
+27 ;;^UTILITY(U,$J,358.3,36267,0)
+28 ;;=20600^^140^1843^5^^^^1
+29 ;;^UTILITY(U,$J,358.3,36267,1,0)
+30 ;;=^358.31IA^3^2
+31 ;;^UTILITY(U,$J,358.3,36267,1,2,0)
+32 ;;=2^Drain/Inject, Joint/Bursa
+33 ;;^UTILITY(U,$J,358.3,36267,1,3,0)
+34 ;;=3^20600
+35 ;;^UTILITY(U,$J,358.3,36268,0)
+36 ;;=20605^^140^1843^1^^^^1
+37 ;;^UTILITY(U,$J,358.3,36268,1,0)
+38 ;;=^358.31IA^3^2
+39 ;;^UTILITY(U,$J,358.3,36268,1,2,0)
+40 ;;=2^Asp/Inj Interm Jt(Ac/Wrist/Ankle
+41 ;;^UTILITY(U,$J,358.3,36268,1,3,0)
+42 ;;=3^20605
+43 ;;^UTILITY(U,$J,358.3,36269,0)
+44 ;;=20610^^140^1843^2^^^^1
+45 ;;^UTILITY(U,$J,358.3,36269,1,0)
+46 ;;=^358.31IA^3^2
+47 ;;^UTILITY(U,$J,358.3,36269,1,2,0)
+48 ;;=2^Asp/Inj Maj Jt (Should/Hip/Knee
+49 ;;^UTILITY(U,$J,358.3,36269,1,3,0)
+50 ;;=3^20610
+51 ;;^UTILITY(U,$J,358.3,36270,0)
+52 ;;=20550^^140^1843^6^^^^1
+53 ;;^UTILITY(U,$J,358.3,36270,1,0)
+54 ;;=^358.31IA^3^2
+55 ;;^UTILITY(U,$J,358.3,36270,1,2,0)
+56 ;;=2^Inject Tendon/Ligament/Cyst
+57 ;;^UTILITY(U,$J,358.3,36270,1,3,0)
+58 ;;=3^20550
+59 ;;^UTILITY(U,$J,358.3,36271,0)
+60 ;;=J1100^^140^1843^4^^^^1
+61 ;;^UTILITY(U,$J,358.3,36271,1,0)
+62 ;;=^358.31IA^3^2
+63 ;;^UTILITY(U,$J,358.3,36271,1,2,0)
+64 ;;=2^Dexamethasone Sodium Phos 1 mg
+65 ;;^UTILITY(U,$J,358.3,36271,1,3,0)
+66 ;;=3^J1100
+67 ;;^UTILITY(U,$J,358.3,36272,0)
+68 ;;=J0800^^140^1843^3^^^^1
+69 ;;^UTILITY(U,$J,358.3,36272,1,0)
+70 ;;=^358.31IA^3^2
+71 ;;^UTILITY(U,$J,358.3,36272,1,2,0)
+72 ;;=2^Corticotropin Inj up to 40 units
+73 ;;^UTILITY(U,$J,358.3,36272,1,3,0)
+74 ;;=3^J0800
+75 ;;^UTILITY(U,$J,358.3,36273,0)
+76 ;;=J1040^^140^1843^7^^^^1
+77 ;;^UTILITY(U,$J,358.3,36273,1,0)
+78 ;;=^358.31IA^3^2
+79 ;;^UTILITY(U,$J,358.3,36273,1,2,0)
+80 ;;=2^Methylprednisolone 80 Mg Inj
+81 ;;^UTILITY(U,$J,358.3,36273,1,3,0)
+82 ;;=3^J1040
+83 ;;^UTILITY(U,$J,358.3,36274,0)
+84 ;;=20552^^140^1843^8^^^^1
+85 ;;^UTILITY(U,$J,358.3,36274,1,0)
+86 ;;=^358.31IA^3^2
+87 ;;^UTILITY(U,$J,358.3,36274,1,2,0)
+88 ;;=2^Trigger Point(s) Inj,1-2 Muscles
+89 ;;^UTILITY(U,$J,358.3,36274,1,3,0)
+90 ;;=3^20552
+91 ;;^UTILITY(U,$J,358.3,36275,0)
+92 ;;=20553^^140^1843^9^^^^1
+93 ;;^UTILITY(U,$J,358.3,36275,1,0)
+94 ;;=^358.31IA^3^2
+95 ;;^UTILITY(U,$J,358.3,36275,1,2,0)
+96 ;;=2^Trigger Point(s) Inj,=/> 3 Muscles
+97 ;;^UTILITY(U,$J,358.3,36275,1,3,0)
+98 ;;=3^20553
+99 ;;^UTILITY(U,$J,358.3,36276,0)
+100 ;;=J0588^^140^1843^10^^^^1
+101 ;;^UTILITY(U,$J,358.3,36276,1,0)
+102 ;;=^358.31IA^3^2
+103 ;;^UTILITY(U,$J,358.3,36276,1,2,0)
+104 ;;=2^Xeomin (Incobotulinumtoxin A) 1 Unit
+105 ;;^UTILITY(U,$J,358.3,36276,1,3,0)
+106 ;;=3^J0588
+107 ;;^UTILITY(U,$J,358.3,36277,0)
+108 ;;=97597^^140^1844^2^^^^1
+109 ;;^UTILITY(U,$J,358.3,36277,1,0)
+110 ;;=^358.31IA^3^2
+111 ;;^UTILITY(U,$J,358.3,36277,1,2,0)
+112 ;;=2^Active Wound Care/20 Cm Or <
+113 ;;^UTILITY(U,$J,358.3,36277,1,3,0)
+114 ;;=3^97597
+115 ;;^UTILITY(U,$J,358.3,36278,0)
+116 ;;=97598^^140^1844^1^^^^1
+117 ;;^UTILITY(U,$J,358.3,36278,1,0)
+118 ;;=^358.31IA^3^2
